Breakthrough bioengineered, decellularized Wharton's Jelly matrix platform facilitates precision in vitro targeting of cancer stem cells (CSCs).
The Sanatela™ Matrix is a revolutionary, natural 3-D biomaterial that gives researchers a tool to cultivate and study stem cells, including cancer stem cells. This matrix tissue opens new research opportunities for the development of individualized cancer treatments in the lab and for High-Throughput Drug Screening applications by pharmaceutical and biotechnology companies.
Market Size - USD 33.99 Billion in 2018, Market Growth - CAGR of 4.7%, Market Trends - Demand for Allergy Diagnostics and Therapeutics in the healthcare industryRead More
Allscripts outperforms competitors in the U.K., Australia and Canada on most all implementations done on time and budget while delivering on expectations; Epic Systems proves top vendor in Southeast Asia and the Middle EastRead More
Asia Pacific apheresis equipment market revenue surpassed USD 606 million in 2018 and is set to achieve significant CAGR from 2019 to 2025, driven by increasing incidence of blood related disorders in emerging economies.Read More